Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000139

EVP, Chief Scientific Officer sold 3,231 shares at $490.00 ($1,583,190)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ALTSHULER DAVID · EVP, Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-03 Sale : show line 1 in the form 10b5-1 −3,231 $490.00 $1,583,190 29,743 D
Open-market sales · 3,231 sh · avg $490.00 · $1,583,190
Loading xslF345X05/wk-form4_1741208889.xml…